carvedilol has been researched along with Arteriosclerosis in 5 studies
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is a novel, multiple-action cardiovascular drug that is currently approved in many countries for the treatment of hypertension." | 8.79 | Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. ( Feuerstein, GZ; Ruffolo, RR, 1997) |
| "Carvedilol is a vasodilating, beta-adrenoceptor antagonist currently marketed for the treatment of mild to moderate hypertension." | 4.79 | Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. ( Feuerstein, GZ; Ruffolo, RR, 1995) |
| "Carvedilol is a novel, multiple-action cardiovascular drug that is currently approved in many countries for the treatment of hypertension." | 4.79 | Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. ( Feuerstein, GZ; Ruffolo, RR, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Severino, M | 1 |
| Giacomini, T | 1 |
| Verrina, E | 1 |
| Prato, G | 1 |
| Rossi, A | 1 |
| Feuerstein, GZ | 3 |
| Ruffolo, RR | 3 |
| Fisher, M | 1 |
| Nunnart, J | 1 |
| Donetti, E | 1 |
| Soma, MR | 1 |
| Barberi, L | 1 |
| Paoletti, R | 1 |
| Fumagalli, R | 1 |
| Roma, P | 1 |
| Catapano, AL | 1 |
2 reviews available for carvedilol and Arteriosclerosis
| Article | Year |
|---|---|
Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Antioxidants; Arteriosclerosis; Carb | 1995 |
Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Arteriosclerosis; Carbazoles; Cardiov | 1997 |
3 other studies available for carvedilol and Arteriosclerosis
| Article | Year |
|---|---|
Reversible cerebral vasoconstriction complicating cerebral atherosclerotic vascular disease in Schimke immuno-osseous dysplasia.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Carvedilol; Child; Clopidogrel; Diagnosis, Differential; | 2018 |
Carvedilol inhibits aortic lipid deposition in the hypercholesterolemic rat.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Arteriosclerosis; Calcium Channel Blockers; C | 1997 |
Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Anticholesteremic Agents; Antihypertensive Agents; Antioxidant | 1998 |